HER2-Positive Metastatic Breast Cancer: What’s New in Treatment and Quality-of-Life
Update: 2025-06-06
Description
- HER2-Positive Metastatic Breast Cancer
- Biomarker, Genomic & Diagnostic Testing: Grade & Hormone Receptors
- Standard Treatment Options, Including Targeted Therapy
- How Biomarker Testing Informs Treatment Decisions
- New & Emerging Targeted Treatments
- Updates on Investigational New Drugs in Clinical Trials
- How Research Contributes to Your Treatment Options
- What’s New in the Prevention & Management of Treatment Side Effects, Symptoms, Discomfort, Neuropathy, Pain & Long-Term Effects
- Guidelines to Prepare for Telemedicine/Telehealth Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes
- Key Questions to Ask Your Health Care Team About Quality-of-Life Concerns
- Questions for Our Panel of Experts
- Biomarker, Genomic & Diagnostic Testing: Grade & Hormone Receptors
- Standard Treatment Options, Including Targeted Therapy
- How Biomarker Testing Informs Treatment Decisions
- New & Emerging Targeted Treatments
- Updates on Investigational New Drugs in Clinical Trials
- How Research Contributes to Your Treatment Options
- What’s New in the Prevention & Management of Treatment Side Effects, Symptoms, Discomfort, Neuropathy, Pain & Long-Term Effects
- Guidelines to Prepare for Telemedicine/Telehealth Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes
- Key Questions to Ask Your Health Care Team About Quality-of-Life Concerns
- Questions for Our Panel of Experts
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
